Clinical Trials Logo

Sleep Disorder clinical trials

View clinical trials related to Sleep Disorder.

Filter by:
  • Recruiting  
  • « Prev · Page 10

NCT ID: NCT03326765 Recruiting - Sleep Disorder Clinical Trials

Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)

Start date: September 27, 2017
Phase: N/A
Study type: Interventional

The proposed research project is aimed at further characterization of sleep problems and evaluation of their impact in children and adults with TSC, excluding epilepsy as contributing factor. Questionnaire-based studies have shown that sleep problems occur in up to half of the children and a third of adults with tuberous sclerosis complex (TSC). However, there is only limited information on the nature of sleep problems and their impact on patients with TSC and their families.

NCT ID: NCT03320382 Recruiting - Asthma Clinical Trials

Multiple Breath Washout, a Clinimetric Dataset

Start date: May 5, 2017
Phase:
Study type: Observational

Monitoring patients with chronic, inflammatory airways disease particularly in the early stages is hampered by the relative insensitivity of current outcome measures to detect subtle changes. Multiple breath washout is a potential sensitive test that is a useful readout of disease at these early stages but it lacks standardisation and knowledge of variability with reference to standard lung function measures. This is a Cross sectional and longitudinal observation study. The hypothesis is that multiple breath washout-derived indices will provide a robust signal of gas mixing inhomogeneity, correlating with conventional measures of airway disease severity. Multiple breath washout performed on different devices will generate indices which correlate but differ in value.

NCT ID: NCT03274505 Recruiting - Stroke Clinical Trials

Sleep Disorders in Transient Ischemic Attack and Stroke: SOMN'AIC Study

SOMN'AIC
Start date: November 14, 2017
Phase:
Study type: Observational

Sleep disorders in the setting of stroke are numerous, including sleep-related breathing disorders, insomnia, excessive daytime sleepiness and restless legs syndrome. Consequences of theses sleep disturbances include impaired functional outcome and quality of life, anxious and depressive troubles and increased cardio-vascular morbi-mortality. Mechanisms underlying sleep disorders in the setting of stroke are complex and still partly elucidated. They probably involve the consequences of the ischemic lesion and of the handicap, but also of associated vascular risk factors and more generally pre-existent medical history, or they could represent themselves a risk factor for stroke. Transient ischemic attack (TIA) is a particular condition in which risk factors and background of patients are similar to that observed in stroke, without any cerebral lesion and no persistent neurological deficit. The main objective of the SOMN'AIC study is to compare the prevalence of sleep disorders in stroke and in transient ischemic attack (TIA). The study hypothesis is that the prevalence of sleep disorders may be higher in stroke than in TIA patients, reflecting the consequences of the lesion and the associated handicap.

NCT ID: NCT01922999 Recruiting - Clinical trials for Chronic Kidney Disease

Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders

Start date: December 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The study will evaluate the safety and efficacy of melatonin supplementation in CKD and ESRD patients with sleep disorders to reduce sleep latency times, the number of apnea/hypopneic episodes, and prolong duration in rapid eye movement (REM) sleep in CKD and ESRD patients with sleep disordered breathing.

NCT ID: NCT00822679 Recruiting - Clinical trials for Acute Coronary Syndrome

Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome

Start date: October 2007
Phase: Phase 4
Study type: Interventional

The purpose of the study is to examine the effects of Eszopiclone, a sleep aid, on inflammatory mediators and coagulability in patients with a recent myocardial infarction.